CVE-2023-40153 Cross-site Scripting in DEXMA DEXGate

Medium 5.4 Published 19 Oct 2023 Updated 11 Sep 2024

An attacker can inject arbitrary JavaScript via the hostname parameter in DEXMA DexGate, potentially executing code or stealing data.

Exploited in the wild: Not known
Login needed: Any signed-in user
Attackable: Over the internet
Victim action needed: Not needed
Fix: None listed

What is CVE-2023-40153?

CVE-2023-40153 is a medium-severity cross-site scripting vulnerability in DEXMA DexGate, published on 19 Oct 2023. Any signed-in user can exploit it over the network, with no action from the victim.

Official description

The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.

Weakness: CWE-79

Which versions are affected by CVE-2023-40153?

It affects 1 product.

Products include Dexma Dexgate.

How do I fix CVE-2023-40153?

No fix has been published for CVE-2023-40153 yet. Limit exposure of the affected software until one is available.

Escape output for the context it lands in and set a strict Content Security Policy. Upgrading the affected component is the real fix. More about Cross-site scripting.

Is CVE-2023-40153 being exploited?

There is no known exploitation of CVE-2023-40153 in the wild and no public exploit code.

Sources

Also known as GHSA-pwfh-gp98-cccx.